Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community‐Based Cohort of Atrial Fibrillation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Mayo Clinic proceedings

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mayocp.2017.09.021PMID 29329798PMCID PMC5814135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrial fibrillation, cognitive impairment, and neuroimaging

  2016cited by this paper
• Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.

  2016cited by this paper
• Decade-long trends in atrial fibrillation incidence and survival: a community study.

  2015cited by this paper
• Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia

  2015cited by this paper
• Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage

  2015cited by this paper
• Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds

  2015cited by this paper
• Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.

  2014cited by this paper
• National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

  2014cited by this paper
• Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds

  2014cited by this paper
• Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation

  2014cited by this paper
• Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)

  2014cited by this paper
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

  2014cited by this paper
• Cognitive Impairment Associated With Atrial Fibrillation

  2013cited by this paper
• Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function.

  2013cited by this paper
• Cognitive Impairment Associated With Atrial Fibrillation

  2013cited by this paper
• Cognitive impairment and dementia after intracerebral hemorrhage: a cross-sectional study of a hospital-based series.

  2013cited by this paper
• New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up.

  2013cited by this paper
• Dementia and risk of adverse warfarin-related events in the nursing home setting.

  2012cited by this paper
• Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

  2012cited by this paper
• History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

  2012cited by this paper
• Recommendations for optimal ICD codes to study neurologic conditions

  2012cited by this paper
• Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

  2012cited by this paper
• Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

  2012cited by this paper
• Cerebral microbleeds are associated with worse cognitive function

  2012cited by this paper
• IC‐02‐02: Predicting progression to Alzheimer's Disease in MCI using combined structural imaging and CSF biomarkers

  2011cited by this paper
• Incidence of dementia and cognitive impairment, not dementia in the united states

  2011cited by this paper
• Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Systematic Review of Published and Unpublished Studies

  2010cited by this paper
• Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage

  2009cited by this paper
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

  2008cited by this paper
• Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

  2007cited by this paper
• Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort.

  2007cited by this paper
• Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

  2006cited by this paper
• Cardiovascular magnetic resonance of left ventricular pseudoaneurysm

  2005cited by this paper
• Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

  2004cited by this paper
• Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation

  2004cited by this paper
• Silent brain infarcts and the risk of dementia and cognitive decline.

  2003cited by this paper
• Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study

  2003cited by this paper
• Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

  2001cited by this paper
• Major bleeding during anticoagulation after cerebral ischemia

  1999cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.

  1994cited by this paper
• A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

  1993cited by this paper
• Effect of Chronic Atrial Fibrillation on Regional Cerebral Blood Flow

  1980cited by this paper

• Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients

  2025cites this paper
• Pattern of anticoagulation prescription for elderly atrial fibrillation patients with or without severe dementia: A retrospective analysis of patient data

  2025cites this paper
• Atrial Fibrillation-Related Ischemic Stroke and Cognitive Impairment: Research Progress on the Characteristics and Pathogenesis.

  2025cites this paper
• Fazekas score predicts cognitive decline & frailty in older adults: insights from the SAGE-AF cohort study

  2025cites this paper
• The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis

  2024cites this paper
• Association of Atrial Fibrillation and Cognitive Dysfunction: A Comprehensive Narrative Review of Current Understanding and Recent Updates

  2024cites this paper
• Factors associated with cognitive impairment in patients with atrial fibrillation: A systematic review and meta-analysis.

  2024cites this paper
• Could the Early Detection of Atrial Fibrillation Reduce the Risk of Developing Dementia?

  2024cites this paper
• Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold

  2024cites this paper
• Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.

  2024cites this paper
• Effect of different oral anticoagulants on cognitive function in patients with atrial fibrillation: A Bayesian network meta-analysis

  2024influential citation
• Exploring the Link between Anticoagulation, Cognitive Impairment and Dementia in Atrial Fibrillation: A Systematic Review

  2024cites this paper
• Atrial Fibrillation and Dementia: Pathophysiological Mechanisms and Clinical Implications

  2024cites this paper
• Cognitive function in atrial fibrillation: A narrative review of evidence and mechanisms

  2024cites this paper
• All-Cause Death and Major Adverse Events in Atrial Fibrillation with Frailty: Observations from the Korea National Health Insurance Service Data

  2024cites this paper
• Atrial fibrillation increases the risk of all-cause dementia, Alzheimer's disease, and vascular dementia: A cohort study of 373, 415 participants in the UK Biobank.

  2024cites this paper
• Association of direct oral anticoagulants and warfarin with incidence of dementia in atrial fibrillation patients: A systematic review and meta-analysis

  2024cites this paper
• Impact of cognitive impairment on clinical outcomes in elderly patients with atrial fibrillation: ANAFIE Registry

  2023cites this paper
• Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches

  2023cites this paper
• Mapping the interplay of atrial fibrillation, brain structure, and cognitive dysfunction

  2023cites this paper
• Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation.

  2023cites this paper
• Does asymptomatic atrial fibrillation exist?

  2023cites this paper
• Genetic Evidence for Causal Association Between Atrial Fibrillation and Dementia: A Mendelian Randomization Study

  2023cites this paper
• Anticoagulants and Dementia: A Systematic Review

  2023influential citation
• Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study

  2023cites this paper
• Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

  2023cites this paper
• The “obesity paradox” in patients with atrial fibrillation: Insights from the Gulf SAFE registry

  2022cites this paper
• Mit NOAK seltener Demenz

  2022cites this paper
• Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration

  2022cites this paper
• Remote magnetic navigation for treatment of patients with atrial fibrillation

  2022cites this paper
• Mechanisms and clinical manifestations of cognitive decline in atrial fibrillation patients: potential implications for preventing dementia.

  2022cites this paper
• Impact of Medication Adherence on the Association Between Oral Anticoagulant Use and Risk of Dementia: A Retrospective Cohort Study using the Japanese Claims Database

  2022cites this paper
• Additional Effects of Antiplatelet Therapy on Anticoagulant Agents in Patients With Bioprosthetic Valves and Atrial Fibrillation.

  2021cites this paper
• Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study

  2021cites this paper
• New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention

  2021cites this paper
• Prevention of Dementia in Patients with Atrial Fibrillation

  2021cites this paper
• A systematic review and meta‐analysis to determine the effect of oral anticoagulants on incidence of dementia in patients with atrial fibrillation

  2021cites this paper
• Association between Circulating Protein C Levels and Incident Dementia: The Atherosclerosis Risk in Communities Study

  2021cites this paper
• Global cognitive performance at 4-year follow-up in individuals with atrial fibrillation-findings from The Irish Longitudinal Study on Ageing.

  2021cites this paper
• Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation

  2021cites this paper
• DOACs and Dementia in Patients with Atrial Fibrillation

  2021cites this paper
• Performance of the Panbio COVID-19 Rapid Antigen Test Device for infection control purposes

  2021cites this paper
• Oral Anticoagulants can Improve Functional Outcomes for Survivors of Spontaneous Intracerebral Hemorrhage

  2021cites this paper
• Atrial fibrillation in aging Methodological aspects and the relation to dementia and cerebral vascular disease

  2021cites this paper
• Фибрилляция предсердий и когнитивные нарушения: распространенность и патогенетические механизмы взаимосвязи (часть 1)

  2020cites this paper
• Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation

  2020cites this paper
• Atrial fibrillation: villain or bystander in vascular brain injury

  2020cites this paper
• Mobile health assessments of geriatric elements in older patients with atrial fibrillation: The Mobile SAGE-AF Study (M-SAGE)

  2020cites this paper
• Pathophysiological mechanisms and therapeutic management of cognitive impairment in patients with atrial fibrillation

  2020cites this paper
• Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation.

  2020cites this paper
• Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer’s disease

  2020cites this paper
• Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management

  2020cites this paper
• Is there a connection among atrial fibrillation, anticoagulant treatment, and dementia?

  2020cites this paper
• Atrial Fibrillation and Cognitive Impairment: An Associated Burden or Burden by Association?

  2020influential citation
• Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE‐AF

  2020cites this paper
• Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.

  2019cites this paper
• Anticoagulation in atrial fibrillation and cognitive decline

  2019cites this paper
• Catheter ablation of atrial fibrillation reduces the risk of dementia and hospitalization during a very long-term follow-up.

  2019cites this paper
• Oral anticoagulants and risk of dementia: A systematic review and meta‐analysis of observational studies and randomized controlled trials

  2019influential citation
• Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal

  2019cites this paper
• Sarcopenia, frailty, cognitive impairment and mortality in elderly patients with non-valvular atrial fibrillation

  2019cites this paper
• Sarcopenia, frailty, cognitive impairment and mortality in elderly patients with non-valvular atrial fibrillation.

  2019cites this paper
• Fibrilación auricular y función cognitiva. Revisión JACC Tema de la semana

  2019cites this paper
• Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study

  2019cites this paper
• Cognitive dysfunction in atrial fibrillation

  2018cites this paper
• Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation

  2018cites this paper
• Reducing Risk of Dementia in AF-Is Oral Anticoagulation the Key?

  2018cites this paper
• Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

  2018cites this paper
• In Reply-Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

  2018cites this paper
• Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review

  2018cites this paper
• Atrial fibrillation, antithrombotic treatment, and cognitive aging

  2018cites this paper
• oral anticoagulants are associated with lower risk of dementia in patients with atrial

  year unknowncites this paper